Cargando…
SARAH Domain-Mediated MST2-RASSF Dimeric Interactions
RASSF enzymes act as key apoptosis activators and tumor suppressors, being downregulated in many human cancers, although their exact regulatory roles remain unknown. A key downstream event in the RASSF pathway is the regulation of MST kinases, which are main effectors of RASSF-induced apoptosis. The...
Autores principales: | Sánchez-Sanz, Goar, Tywoniuk, Bartłomiej, Matallanas, David, Romano, David, Nguyen, Lan K., Kholodenko, Boris N., Rosta, Edina, Kolch, Walter, Buchete, Nicolae-Viorel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055338/ https://www.ncbi.nlm.nih.gov/pubmed/27716844 http://dx.doi.org/10.1371/journal.pcbi.1005051 |
Ejemplares similares
-
Structural basis of the heterodimerization of the MST and RASSF SARAH domains in the Hippo signalling pathway
por: Hwang, Eunha, et al.
Publicado: (2014) -
Phosphorylation of RAF Kinase Dimers Drives Conformational Changes that Facilitate Transactivation
por: Jambrina, Pablo G., et al.
Publicado: (2015) -
Competing to coordinate cell fate decisions: the MST2-Raf-1 signaling device
por: Nguyen, Lan K, et al.
Publicado: (2015) -
The SARAH Domain of RASSF1A and Its Tumor Suppressor Function
por: Dittfeld, Claudia, et al.
Publicado: (2012) -
RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy
por: García-Gutiérrez, Lucía, et al.
Publicado: (2020)